NetworkNewsBreaks – Brain Scientific Inc. (BRSF)
Post# of 129
Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, has created powerful yet affordable solutions that bring brain diagnostics to settings where it was previously impossible or difficult to conduct neurological testing. Concussions resulting from head trauma in contact sports are usually minor; however, some can lead to significant long-term cognitive, physical and psychosocial impairments. “Unfortunately,” observes a recent article, “at this moment, it is challenging to differentiate between the two.” CT is the most commonly used imaging procedure but is not effective when conducting a post-concussion examination. MRIs and neuropsychologic testing are somewhat more effective but are time-consuming. Even so, EEG and qualitative EEG (“QEEG”) procedures are proving valuable; their value may lie in pre- and post-concussion comparisons where pre-trauma readings would be compared to post-trauma readings of the same patient. “With portable devices, sideline-based concussion assessment could help identify indicators consistent with acute TBI [traumatic brain injury] and concussion during the game. Portable EEG diagnostics is precisely the space that BRSF aims to revolutionize. With the company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), it is now possible to conduct quick and reliable EEG testing in minutes… to diagnose concussions and other head trauma that occur on the field without transporting a patient to the hospital.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer